Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

P Soriano1, C Montgomery, R Geske

  • 1Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030.

Cell
|February 22, 1991
PubMed

Insights

The c-src proto-oncogene is essential for normal bone remodeling and osteoclast function. Mice lacking c-src exhibit impaired bone formation and osteopetrosis, demonstrating its critical role in skeletal development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • The c-src proto-oncogene is a non-receptor tyrosine kinase implicated in various cellular processes.
  • Its precise physiological role, particularly in normal development and tissue homeostasis, remains incompletely understood.

Purpose of the Study:

  • To elucidate the normal physiological function of the c-src proto-oncogene.
  • To investigate the consequences of a null mutation in the c-src gene on mouse development and physiology.

Main Methods:

  • Generation of c-src null mutant mice using homologous recombination in embryonic stem cells.
  • Analysis of homozygous mutant mice through histological and hematological examinations.
  • Assessment of bone remodeling and osteoclast function in mutant mice.

Main Results:

  • Homozygous c-src mutant mice exhibit impaired bone remodeling and develop osteopetrosis.
  • Osteoclast function is significantly impaired in the absence of c-src.
  • No detectable abnormalities were observed in the brain or platelets, despite high c-src expression in these tissues.

Conclusions:

  • The c-src proto-oncogene is not essential for general cell viability, likely due to functional redundancy with related tyrosine kinases.
  • c-src plays a critical and essential role in bone formation and osteoclast-mediated bone remodeling.
  • Targeting c-src may offer therapeutic potential for bone-related disorders.